Role of Traditional Cardiovascular Risk Factors for the Occurrence of Erectile Dysfunction in Patients with Coronary Artery Disease


Background: Erectile Dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient to permit satisfactory sexual intercourse. Erectile dysfunction affects more than 150 million men worldwide and impairs psychological well-being and personal relationships, hence quality of life. Recent studies have shown that ED is present in 42% to 76% of men with coronary artery disease (CAD). Epidemiological study showed clearly role of traditional cardiovascular risk factors such as diabetes, hypertension, dyslipidemia and smoking in CAD. Erectile dysfunction and vascular diseases share a similar risk factors and pathogenic involvement of nitric oxide (NO)-pathway leading to impairment of endothelium-dependent vasodilatation (early phase) and structural vascular abnormalities (late phase). This study was conducted to determine whether the stable CAD patients who have traditional cardiovascular risk factors has a higher risk for ED compared with stable CAD patients without traditional cardiovascular risk factors.
Methods: We performed an age matched-paired case control study. Men with CAD documented by angiography were evaluated for ED. Erectile function was assessed by a 5-item version of the International Index of Erectile Function (IIEF-5). Traditional cardiovascular risk factors such as diabetes, hypertension, dyslipidemia and cigarette smoking were assesed. Depression and anxiety were screened using Indonesian version of Hospital Anxiety and Depression Scale (HADS). Basic demographic and other variables were also collected.
Results: This study evaluated 127 men, 96.8% of them had traditional cardiovascular risk factors, 25.2% had diabetes mellitus, 77.2% had dyslipidemia, 55.9% had hypertension and 64.6% were smoker. Traditional cardiovascular risk factors was strongly associated with ED (OR=10.67 [1.25-232.83]). ED was independently associated with diabetes mellitus (OR=4.17 [1.14-15.24]), hypertension (OR=2.64 [1.07-6.49]) and cigarette smoking (OR=2.26 [1.01-5.75]).
Conclusion: CAD patients with traditional cardiovascular risk factor had more risk for developing ED than those with no traditional cardiovascular risk factor.


Download data is not yet available.


1. Delima, Mihardja L, Siswoyo H. Prevalensi dan faktor determinan penyakit jantung di Indonesia. Bul. Penelit. Kesehatan. 2009;37:142-159.

2. NIH Consensus Statement. Impotence. 1992;10(4):1-31.

3. Lasker GF, Maley JH, Kadowitz PJ. A Review of the pathophysiology and novel treatments for erectile dysfunction. Advances in Pharmacological Science. 2010;730861.

4. Montorsi F, Briganti A, Salonia A, et al. Erectile dysfunction prevalence: Time of onset and associationwith risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. European Urology. 2003;44:360–365.

5. Shanker ASR, Phanikrishna B, Reddy CBV. Association between erectile dysfunction and coronary artery disease and its severity. Indian Heart Journal. 2013;65:180-186.

6. Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: The COBRA trial. Eur Heart J. 2006;27:2632–9.

7. Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat. Rev. Cardiol. 2014;11:276-289

8. Walczak MK, Lokhanwala NL, Hodge MB, Guay AT. Prevalence of cardiovascular risk factor in erectile dysfunction. J Gend Spesif Med. 2002;5(6):19-24.

9. Junior EDM, Beslane WJ, Bartolo EB, Filtlipadi JAS. Prevalence and determinants of erectile dysfunction in Santos, southeastern Brazil. Sao Paulo Med J/Rev Paul Med. 2002;120(2):49-54.

10. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. The American Journal of Medicine. 2007;120: 151-157.

11. Feldman AA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts male aging study. Preventive Medicine. 2000;30:328–338.

12. Kloner RA. A case of erectile dysfunction and risk factors for coronary artery disease. International Journal of Impotence Research. 17:S7–S11.

13. Vural M, Basar, E. Impact of psychological factors on development and course of coronary heart disease: should be negative psychological factors altered? Anadolu Kardiyoloji Dergisi. 2006;6(1):55-9.

14. Steiger A, Holsboer F, Benkert O. Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with mayor depression and in normal controls. Acta Psychiatrica Scandinavica. 1993;87:358-63.

15. Vasan RS, Sullivan LM, Wilson WF, et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005;142:393-402.

16. Nicholson A, Kuper H, Hemingway H. Depression as a etiologic and prognostic factor in coronary heart disease: a meta analysis of 6362 events among 146.538 participants in 54 observational study. Eur Heart J. 2006;27:2763-2774.

17. Zedan H, Hareadei AA, Abd-Elsayed AA, Abdel-Maquid EM. Cigarette smoking, hypertension and diabetes mellitus as risk factors for erectile dysfunction in upper Egypt. EMHJ 2010;16(3):281-285.

18. Walker CN, Meller S, Stilp E, Mena-Hurtado C. Erectile dysfunction and cardiovascular disease: A review. J Androl Gynaecol. 2013;1(2):10.

19. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, et al. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol. 2001;166(2):569-574.

20. Grover SA, Lowensten I, Kaouache M, et al. The prevalence of erectile dysfunction in the primary care setting. Arch Intern Med. 2015;166:213-219.

21. Weber MF, Smith DP, O’Connell DL, et al. Risk factors for erectile dysfunction in a cohort of 108477 Australian men. Med J Aust. 2013;199(2):107-111.

22. Romeo JH, Seftel AD, Mahdun ZT, Aron DC. Sexual function in men with diabetes type 2: Association with glycemic control. The Journal of Urology. 2000;163:788-791.

23. Yang R, Yang B, Wen Y, et al. Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats. J Sex Med. 2009;6(3):696–707.

24. Al Naimi A, Majzoub AA, Talib RA, et al. Erectile dysfunction in Qatar: Prevalence and risk factors in 1,052 participants—A pilot study. Sex Med. 2014;2:91–95.
25. Nunes KP, Labazi H, Webb RC. New insight into hypertension-associate erectile dysfunction. Curr Opin Nephrol Hypertens.2012;21(2):163-170.

26. Nicolosi A, Glasser DB, Moreira ED, Villa M. Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: A population study. International Journal of Impotence Research. 2003.15:253–257.

27. Mirone V, Imbimbo C, Bortolotti A, et al. Cigarette smoking as risk factor for erectile dysfunction: Results from an Italian epidemiological study. Eur Urol. 2002;41(3):294-297.

28. Gades NM, Nehra A, Jacobson DJ, et al. Association between smoking and erectile dysfunction: A population-based study. Am. J. Epidemiol. 2005;161(4):346-351.

29. Elbendary MA, El-Gamal OM, Salem KA. Analysis of risk factors for organic erectile dysfunction in Egyptian patients under the age of 40 years. Journal of Andrology. 2009;30(5):520-524.

30. Tostes RC, Carneiro FS, Lee A, et al. Cigarette smoking and erectile dysfunction: Focus on NO bioavailability and ROS generation. J Sex Med. 2008;5:1284–1295.
How to Cite
Role of Traditional Cardiovascular Risk Factors for the Occurrence of Erectile Dysfunction in Patients with Coronary Artery Disease. (2017). Indonesian Journal of Cardiology, 37(3), 137-44.
Clinical Research